ArticleFrontiers in virology (Lausanne, Switzerland)2023

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses.

Pradeepa Pushparaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.